How can employers tackle rising specialty drug costs?
Richard Stolz is a freelance writer based in Rockville, Md.
Richard Stolz is a freelance writer based in Rockville, Md.
For reprint and licensing requests for this article, click here.
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
A financial spreadsheet alone cannot capture the total value and performance of a benefits program, nor can numbers on a ledger guarantee long-term operational success.
The health and welfare leader and 2026 Excellence in Benefits honoree is guiding the bank in navigating them all.
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
As costs to treat serious conditions surge, employers must plan how to absorb budget-altering expenses ahead of time.